Cardiovascular diseases (CVD) account for a significant, and growing, global healthcare burden with more than 500 million people affected worldwide.2 There are many options in managing CVD, however the delivery of optimal care is complicated due to constraints in healthcare workforce, financing, availability and affordability of CVD medicine and service delivery.